2018 – Page 23 – Policy & Medicine

Is There a Decrease in FDA Regulations?

Higher Outpatient Drug Spending At 340B Hospitals, According to New Analysis

House Subcommittee on Health Holds Hearing on MACRA

House Finally Passes Right to Try. If First You Don’t Succeed, Try, Try Again.

FDA Transparency Blueprint Issued

Oregon: Transparency’s Latest Frontier

Alere Settles False Claims Act Allegations for $33.2 Million

NQF Issues Guidance on Opioid Prescribing Practices

Teva and McCaskill: A Game of Cat and Mouse

Preparing for the 2018 Ethical MedTech, APACMed, and China Codes